Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma

Environmental and Molecular Mutagenesis

Volumn 56, Issue 1, 2015, Pages 70-76

  Song, Chang Myeon ^a   Kwon, Tack Kyun ^b   Park, Byung Lae ^c   Ji, Yong Bae ^a   Tae, Kyung ^a  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c Department of Genetic Epidemiology SNP Genetics ^*  (South Korea)

Author keywords

Ataxia telangiectasia mutated; Genetic polymorphism; Papillary thyroid carcinoma; Single nucleotide polymorphism

Indexed keywords

ATM PROTEIN; ATM PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA; CANCER STAGING; CARCINOMA, PAPILLARY; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; PROGNOSIS; RISK FACTOR; THYROID NEOPLASMS;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; THYROID NEOPLASMS;

EID: 84921535063     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21898     Document Type: Article

References (36)

1. Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, Mitsutake N, Kominami R, Yamashita S. 2009. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 16: 491-503.
2. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard J, Hall J. 2003. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717-8725.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4. Chen T, Dong B, Lu Z, Tian B, Zhang J, Zhou J, Wu H, Zhang Y, Wu J, Lin P, Xu H, Mo X. 2010. A functional single nucleotide polymorphism in promoter of ATM is associated with longevity. Mech Ageing Dev 131:636-640.
5. Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, Kim KW, Yi KH, Chung JK, Youn YK, Cho NH, Park DJ, Koh CS. 2013. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 23:797-804.
6. Chung JH. 2014. A Refutation against Unfounded Reports on Thyroid Cancer. J Korean Thyroid Assoc 7:1-6.
7. Davies L, Welch HG. 2006. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
8. Dean DS, Gharib H. 2008. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:901-911.
9. Dombernowsky SL, Weischer M, Allin KH, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. 2008. Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 26:3057-3062.
10. Gatzidou E, Michailidi C, Tseleni-Balafouta S, Theocharis S. 2010. An epitome of DNA repair related genes and mechanisms in thyroid carcinoma. Cancer Lett 290:139-147.
11. Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. 2001. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93:288-293.
12. Gu Y, Yu Y, Ai L, Shi J, Liu X, Sun H, Liu Y. 2014. Association of the ATM gene polymorphisms with papillary thyroid cancer. Endocrine 45:454-61.
13. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K. 2009. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.
14. Jackson SP. 2002. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-696.
15. Kim JH, Kim H, Lee KY, Choe KH, Ryu JS, Yoon HI, Sung SW, Yoo KY, Hong YC. 2006. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 15:1181-1186.
16. Landi S, Gemignani F, Canzian F, Gaborieau V, Barale R, Landi D, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gioia-Patricola L, Hall J, Boffetta P, Hung RJ, Brennan P. 2006. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 66:11062-11069.
17. Lavin MF, Kozlov S. 2007. ATM activation and DNA damage response. Cell Cycle 6:931-942.
18. Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D. 2005. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:821-825.
19. Lee SA, Lee KM, Lee SJ, Yoo KY, Park SK, Noh DY, Ahn SH, Kang D. 2010. Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk. Nutr Cancer 62:1087-1094.
20. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, Li Y, Chang P, Abbruzzese JL. 2009. DNA repair gene polymorphisms and risk of pancreatic cancer Clin Cancer Res 15:740-746.
21. Little JB. 2000. Radiation carcinogenesis. Carcinogenesis 21:397-404.
22. Livak KJ. 1999. Allelic discrimination using fluorogenic probes and the 5 ' nuclease assay. Genet Anal 14:143-149.
23. Lo YL, Hsiao CF, Jou YS, Chang GC, Tsai YH, Su WC, Chen YM, Huang MS, Chen HL, Yang PC, Chen CJ, Hsiung CA. 2010. ATM polymorphisms and risk of lung cancer among never smokers. Lung Cancer 69:148-154.
24. Neta G, Brenner AV, Sturgis EM, Pfeiffer RM, Hutchinson AA, Aschebrook-Kilfoy B, Yeager M, Xu L, Wheeler W, Abend M, Ron E, Tucker MA, Chanock SJ. 2011. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis 32:1231-1237.
25. Peterson CL, Cote J. 2004. Cellular machineries for chromosomal DNA repair. Genes Dev 18:602-616.
26. Rotman G, Shiloh Y. 1998. ATM: From gene to function. Hum Mol Genet 7:1555-1563.
27. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
28. Savitsky K, Platzer M, Uziel T, Gilad S, Sartiel A, Rosenthal A, Elroy-Stein O, Shiloh Y, Rotman G. 1997. Ataxia-telangiectasia: Structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression. Nucleic Acids Res 25:1678-1684.
29. Shahbazi-Gahrouei D, Gholami M, Setayandeh S. 2013. A review on natural background radiation. Adv Biomed Res 2:65.
30. Shen L, Yin ZH, Wan Y, Zhang Y, Li K, Zhou BS. 2012. Association between ATM polymorphisms and cancer risk: a meta-analysis. Mol Biol Rep 39:5719-5725.
31. Shiloh Y, Ziv Y. 2013. The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14:197-210.
32. Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM. 1998. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345.
33. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
34. Tamimi RM, Hankinson SE, Spiegelman D, Kraft P, Colditz GA, Hunter DJ. 2004. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study. Breast Cancer Res 6:R416-422.
35. Xu L, Morari EC, Wei Q, Sturgis EM, Ward LS. 2012. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. J Clin Endocrinol Metab 97:1913-1921.
36. Ye C, Dai Q, Lu W, Cai Q, Zheng Y, Shu XO, Gu K, Gao YT, Zheng W. 2007. Two-stage case-control study of common ATM gene variants in relation to breast cancer risk. Breast Cancer Res Treat 106:121-126.